Eherer A J, Schwetz I, Hammer H F, Petnehazy T, Scheidl S J, Weber K, Krejs G J
Department of Internal Medicine, Karl-Franzens University, Graz, Austria.
Gut. 2002 Jun;50(6):758-64. doi: 10.1136/gut.50.6.758.
Sildenafil blocks phosphodiesterase type 5 which degrades nitric oxide (NO) stimulated 3'5'-cyclic monophosphate (cGMP), thereby relaxing smooth muscle cells in various organs. We used sildenafil as a tool to investigate the role of the NO-cGMP pathway in the oesophagus of healthy volunteers and patients with hypercontractile oesophageal motility disorders.
Six healthy male volunteers participated in a randomised double blind study on two separate days before and one hour after oral intake of either sildenafil 50 mg or placebo. Oesophageal manometry was performed to determine vector volume of the lower oesophageal sphincter (LOS) and pressure amplitudes of the oesophageal body. Four of the volunteers underwent 12 hour ambulatory oesophageal manometry on two separate days, once with sildenafil 50 mg and once with placebo. An activity index for spontaneous swallowing was calculated for every hour of the study. Eleven patients with hypercontractile oesophageal motility disorders took part in an open study of the effect of 50 mg sildenafil on manometric features of their disorder and on the clinical response to sildenafil taken as required.
In healthy subjects, sildenafil significantly reduced LOS pressure vector volume and pressure amplitudes in the distal half of the oesophageal body. In three of four subjects the inhibitory effect of sildenafil lasted at least eight hours. In nine of 11 patients, manometric improvement after sildenafil was observed but only four had an improvement in oesophageal symptoms with sildenafil taken as required. Two of these four patients however experienced side effects and did not want to continue treatment.
Sildenafil lowers LOS pressure and propulsive forces in the body of the oesophagus of healthy subjects as well as in patients with nutcracker oesophagus, hypertensive LOS, and achalasia. The effect of sildenafil on the oesophageal body may last for up to eight hours in healthy volunteers. A subset of patients with hypertensive LOS or nutcracker oesophagus may benefit from sildenafil but side effects are a limiting factor.
西地那非可阻断5型磷酸二酯酶,该酶能降解一氧化氮(NO)刺激产生的3',5'-环磷酸鸟苷(cGMP),从而使各器官的平滑肌细胞舒张。我们使用西地那非作为工具,来研究NO-cGMP途径在健康志愿者及患有食管动力亢进性疾病患者食管中的作用。
6名健康男性志愿者参与了一项随机双盲研究,在两天内分别于口服50毫克西地那非或安慰剂之前及之后1小时进行。通过食管测压来测定食管下括约肌(LOS)的向量容积及食管体部的压力幅度。其中4名志愿者在两天内分别进行了12小时的动态食管测压,一次服用50毫克西地那非,一次服用安慰剂。计算研究过程中每小时的自发吞咽活动指数。11名患有食管动力亢进性疾病的患者参与了一项开放研究,观察50毫克西地那非对其疾病测压特征的影响以及按需服用西地那非后的临床反应。
在健康受试者中,西地那非显著降低了LOS压力向量容积及食管体部远端一半的压力幅度。4名受试者中有3名,西地那非的抑制作用持续至少8小时。11名患者中有9名在服用西地那非后测压结果有所改善,但按需服用西地那非后只有4名患者的食管症状得到改善。然而,这4名患者中有2名出现了副作用,不想继续治疗。
西地那非可降低健康受试者以及患有胡桃夹食管、LOS高压和贲门失弛缓症患者食管体部的LOS压力及推进力。在健康志愿者中,西地那非对食管体部的作用可能持续长达8小时。一部分LOS高压或胡桃夹食管患者可能从西地那非中获益,但副作用是一个限制因素。